Key facts
- This page summarizes Josep Llorens's Form 4 filing for HAEMONETICS CORP (HAE).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 29 May 2024, 17:42.
Josep Llorens - 28 May 2024 Form 4 Insider Report for HAEMONETICS CORP (HAE)
- Reporting relationship
- EVP, Global Manufacturing
- Issuer ticker
- HAE
- Reported as of
- 28 May 2024
- Net transaction value
- -$431,742
- SEC form
- 4
- Accepted by SEC
- 29 May 2024, 17:42:26 UTC
- Prior SEC filing
- 21 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Thomas V. Powers, attorney-in-fact for Mr. Llorens
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Josep Llorens filed Form 4 for HAEMONETICS CORP (HAE) on 29 May 2024.
Change
- Previous filing in this sequence was filed on 21 May 2024.
- Current net transaction value: -$431,742.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HAE
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +14,140
- Change %
- +66%
- Price
- $0.000000
- Shares after
- 35,450
- Date
- 28 May 2024
- Ownership
- Direct
- Footnotes
- F1, F2
HAE
transaction
Common Stock
Tax liability
- Transaction value
- $431,742
- Shares
- -4,510
- Change %
- -13%
- Price
- $95.73
- Shares after
- 30,940
- Date
- 28 May 2024
- Ownership
- Direct
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on May 18, 2021, based on the issuer's total shareholder return relative to that of the companies comprising the S&P MidCap 400 Index for the performance period from May 18, 2021 to May 17, 2024, as certified by the Compensation Committee of the Board of Directors on May 26, 2024.
Footnote F2
This number includes unvested restricted stock units ("RSUs") previously reported.
Footnote F3
Represents shares withheld for tax obligations in connection with the vesting of certain PSUs reported in Table I.